98%
921
2 minutes
20
Substance use disorder is highly stigmatised despite its contemporary medicalisation. Because of the criminalisation of substance use, parents with substance use disorder must often navigate recovery while interacting with the criminal legal and child welfare systems. Restitution narratives of illness do not sufficiently capture the recovery experiences of parents with substance use disorder whose recoveries may better align with a quest narrative. This study uses qualitative photovoice discussion data to examine the recovery narratives constructed by parents with substance use disorder as they navigate institutional and interpersonal obligations. Using template analysis of 23 transcripts from photovoice group sessions with 29 individuals who have substance use disorder, we find that criminal legal system and child welfare system obligations limit participants' ability to fully engage in the recovery process. Carceral institutions act as a barrier to substance use recovery and parenting capacity by conferring punitive consequences that prioritise restitution. Parents in recovery must navigate these restitutive institutions while seeking self-improvement and using their lived experiences to rebuild community with their families. Understanding parental recovery experiences may inform the improved design and implementation of parenting and behavioural health supports available to help break intergenerational cycles of trauma and addiction.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12311621 | PMC |
http://dx.doi.org/10.1111/1467-9566.70056 | DOI Listing |
JMIR Res Protoc
September 2025
Institute of Higher Education and Research in Healthcare, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Background: In pediatric intensive care units, pain, sedation, delirium, and iatrogenic withdrawal syndrome (IWS) must be managed as interrelated conditions. Although clinical practice guidelines (CPGs) exist, new evidence needs to be incorporated, gaps in recommendations addressed, and recommendations adapted to the European context.
Objective: This protocol describes the development of the first patient- and family-informed European guideline for managing pain, sedation, delirium, and IWS by the European Society of Paediatric and Neonatal Intensive Care.
J Stud Alcohol Drugs
September 2025
National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Background: Historically, cannabis use and cannabis use disorder (CUD) have been more prevalent among males. However, emerging evidence suggests cannabis use may be increasing faster among females in younger age groups. This study characterized changes in female versus male differences in cannabis use and CUD across age groups and time.
View Article and Find Full Text PDFObjectives: Azapirone-class drugs are partial 5-HT1A receptor agonists commonly used to treat anxiety disorders. Prior experimental studies have so far demonstrated that these drugs have low potential for dependence and problematic use and are considered safe treatment options compared with benzodiazepines. However, recent evidence suggesting the contrary raises concerns about their safety.
View Article and Find Full Text PDFObjectives: Cocaine use disorder (CUD) affects 1.4 million people in the United States, yet no FDA-approved treatments exist. In 2023, the Food and Drug Administration (FDA) released a draft guideline on treatments for stimulant use disorders, providing direction for trial design, outcomes, and population selection.
View Article and Find Full Text PDF